RAPINOVET X INTRAVENOUS ANAESTHETIC FOR DOGS AND CATS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

PROPOFOL

Available from:

Intervet Australia Pty Limited

INN (International Name):

propofol(10mg/mL)

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

PROPOFOL UNGROUPED Active 10.0 mg/ml

Units in package:

10 x 20mL; 100mL; 20mL; 50mL

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Therapeutic area:

ANAESTHETICS/ANALGESICS

Therapeutic indications:

ANAESTHETIC - LOCAL/GENERAL | GENERAL ANAESTHETIC | IMMOBILISER | LOCAL ANAESTHETIC | PREMEDICATION | SEDATIVE | TRANQUILLISER | TRAVEL SICKNESS

Product summary:

Poison schedule: 4; Withholding period: WHP: Not to be used in food producing species of animals.; Host/pest details: CAT: [ANAESTHETIC - LOCAL/GENERAL]; DOG: [ANAESTHETIC - LOCAL/GENERAL]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [ANAESTHETIC - LOCAL/GENERAL]; DOG: [ANAESTHETIC - LOCAL/GENERAL]; For intravenous injection.NOT TO BE USED in food producing species of animals

Authorization status:

Stopped

Authorization date:

2021-07-01

Patient Information leaflet

RAPINOVET X (20mL,
50mL,
100mL)
PRIMARY PACK CARTON - MAIN PANEL
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
RAPINOVET® X
Intravenous Anaesthetic
for
Dogs and Cats
ACTIVE CONSTITUENT:
10
mg/mL
PROPOFOL
FOR INTRAVENOUS INJECTION
10 X 20ML
50ML
100ML
Scherlng-Plough Animal
Health
N.R.A.
APPROVED
LABEL
(TEXT)
u,
b
!ll0l..
Label No:
.~~g'ri""'"
.....
:
I
.
Date:
_.;[jz'J
.
.
!;?::-f.2'ri'"
Signature:
./../.'"
',t.
....
.......
i
,
File Name:
Rapinovet
X ANZ cat 38.doc
$chering-Plough Label
&
Printer
Version:
1
Page 1 of 5
Prepared
By:
L.
Wirth
Specifications:
(13/11/2001 )
Preparation Date:
13/11/2001
CCP
00/0"
Last
Revised:
25/9/2001
RAPINOVET
X
(20mL,
50mL,
100mL)
RAPINOVET® X
INTRAVENOUS ANAESTHETIC FOR DOGS AND CATS
PRIMARY
PACK
CARTON
ANCILLARY
PANELS
READ THE ACCOMPANYING LEAFLET BEFORE USING THIS PRODUCT.
EACH ML CONTAINS 10MG PROPOFOL.
DIRECTIONS FOR USE:
RESTRAINT
NOT TO BE USED IN FOOD PRODUCING SPECIES OF ANIMALS.
FOR INTRAVENOUS INJECTION.
SHAKE THOROUGHLY BEFORE USE.
DISCARD THE UNUSED CONTENTS OF THE VIAL WITHIN 24 HOURS OF OPENING.
Propofol
(RAPINOVET X) is a substituted phenol
which,
when given by intravenous injection,
is
a short-acting anaesthetic with a rapid rate of onset.
After a single bolus dose blood level
profiles are characterised by a rapid distribution phase and a rapid
elimination phase.
No
accumulation of
propofol
blood levels has been observed after multiple daily dosing.
Urinary
excretion is the major route of elimination of metabolites from the
body.
RAPINOVET X has been used in association with commonly used
premedicants
ego
atropine,
acepromazine,
diazepam;
inhalational
agents
ego
halothane,
nitrous oxide,
enflurane;
and
analgesic agents
ego
pethidine,
buprenorphine.
No pharmacological
incompatibility has been
encountered.
Inadvertent
perivascular administration has not
been found to produce local
tissue reactions.
WITHHOLDING PERIOD
NOT TO BE USED IN FOOD PRODUCING SPECIES OF ANIMALS.
FOR FURTHER INFORMATION CONTACT SCHERING-PLOUGH CUSTOMER

Summary of Product characteristics

PRODUCT NAME: RAPINOVET X INTRAVENOUS ANAESTHETIC FOR DOGS
AND CATS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: AUGUST, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Water solution of Propofol and other ingredients.
TRADE NAME:
RAPINOVET X INTRAVENOUS ANAESTHETIC FOR DOGS AND CATS
RECOMMENDED USE:
Anaesthetic injection for dog and cats.
APVMA NO:
54046
CREATION DATE:
August, 2009
THIS VERSION ISSUED:
August, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S36, S24/25. Wear suitable protective clothing. Avoid contact with
skin and eyes.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Milky white aqueous emulsion.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
a physiologically active
product and so contact should be minimised, especially if the user is
taking a form of medication, as interactions can
sometimes give unexpected and undesired results.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be irritating, but is unlikely to
cause anything more than mild transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long te